Replies to post #265979 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"At this point, there are hints that something may be up with the manufacturing of the drugs but there is nothing definitive about the start of any phase 3 trials. "

Evonik commercial grade supply PR April 2018
CoreRx sachet PR July 2018

BEVERLY, MA–(Marketwired – October 13, 2015) - Cellceutix Corporation (OTC: CTIX)
"For example, the Company recently received the Brilacidin active pharmaceutical (API) from its contracted manufacturer. The API which has already passed all quality control tests at the manufacturer is now undergoing additional rigorous laboratory testing by our vendors to make certain it’s up to the standards we require for the drug."